Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial

Exclusion Criteria

• •Patient Participants:
• •1. Contraindication to rTMS according to the TMS Adult Safety Screen (TASS) and PI review.
• •2. Have any intracranial implant (e.g., aneurysm clips) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed.
• •3. Pregnant or intending to be pregnant during the study.
• •4. A history of a primary seizure disorder, seizure associated with an intracranial lesion, recurrent seizures related to substance intoxication or withdrawal or recent seizure within the last 6 months.
• •5. Space occupying intracranial lesion.
• •6. Any generalized skin disorders precluding the use of the nicotine patch.
• •7. Any known hypersensitivity or allergies to the nicotine patch.
• •8. Any known life-threatening arrhythmias or severe/worsening angina pectoris.
• •9. Within two weeks of experiencing a myocardial infarction or cerebral vascular accident.
• •10. Currently using or has used nicotine replacement therapy within the past two weeks.
• •11. Diagnosed with a terminal illness
• •12. Current regular use of e-cigarettes or other vaping devices containing nicotine and not willing to stop using these devices for the duration of the study.
• •13. Acutely unstable medical, psychiatric, or substance use disorder comorbidity with safety concerns at the discretion of the PI or study physician.
• •14. Previous treatment with rTMS for smoking cessation
• •15. Treatment with nicotine replacement therapy anytime within the last 1 month